Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
130 Results Found
AHA-supported bills would create data, buffer to help prevent drug shortages
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages.
AHA Letter of Support for the Drug Shortage Prevention Act of 2023
The Drug Shortage Prevention Act would require manufacturers to notify the Food and Drug Administration (FDA) of increased demand of covered drugs. The AHA believes the requirement that manufacturers notify the FDA of increased demand for critical drugs will be an integral tool for shoring up the supply chain.
Pfizer implements emergency ordering process for certain sterile injectables
Pfizer will ship certain sterile injectable products directly to customers due to high demand after a tornado struck the plant that makes them.
FDA assessing supply impact of storm damage to Pfizer sterile injectables plant
The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals, but is working with Pfizer to complete a more extensive assessment and will share more information as it becomes available.
Senate committee advances bill to reauthorize preparedness programs
The Senate Health, Education, Labor and Pensions Committee voted 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333), which would reauthorize the Hospital Preparedness Program at the current funding level of $385 million through fiscal year 2029.
AHA responds to GOP inquiry on drug shortages, shares impact on hospitals and patient care
AHA is weighing in on drug shortages that impact patient care in response to a request by Republican leaders in the House and Senate. Rep. Cathy McMorris Rodgers, R-Wash., chair of the House Committee on Energy and Commerce, and Sen. Mike Crapo, R-Idaho, ranking member of the Senate Finance Committee, sought the information to better understand the issue.
AHA Responds to Request for Information on Drug Shortages
The Honorable Cathy McMorris Rodgers
Chair
Committee on Energy and Commerce
FDA to allow import of oncology drug amid nationwide shortage
The FDA on June 2 told AHA that is has worked with Qilu Pharmaceuticals and Apotex Corp. to temporarily import cisplatin, a drug used in chemotherapy, after a national shortage.
Senate committee, report examine growing drug shortages
New drug shortages increased nearly 30% last year to their highest level in almost five years, according to a report released last week by the Senate Homeland Security and Governmental Affairs Committee for a hearing on the issue.
IV Contrast Media Shortage
The Food and Drug Administration (FDA) continues to report shortages of GE Healthcare’s Omnipaque™ (iohexol) and iodixanol intravenous contrast media products for computed tomography imaging.